Recent Finacing
Recent Raise
BioGliph is a biotech software company that visualizes, registers, and models biologic molecules to design and produce multispecific antibodies for complex therapeutic applications.
Focus Areas
Recent Investors
Funding round
Investor
See the team members at BioGlyph.
